Published in Dig Dis Sci on February 01, 1991
Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ (1994) 1.78
Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol (1991) 1.59
Bisulfite or sulfite inhibits growth of Helicobacter pylori. J Clin Microbiol (1994) 1.13
Helicobacter pylori and gastric cancer: correlation with gastritis, intestinal metaplasia, and tumour histology. Gut (1992) 1.13
Ten year follow up study of lymphocytic gastritis: further evidence on Helicobacter pylori as a cause of lymphocytic gastritis and corpus gastritis. J Clin Pathol (1995) 1.11
Coexistence of eosinophilic gastroenteritis and Helicobacter pylori gastritis: causality versus coincidence. Dig Dis Sci (2001) 1.08
New plate medium for growth and detection of urease activity of Helicobacter pylori. J Clin Microbiol (1992) 0.84
Helicobacter pylori infection and gastric cancer. BMJ (1991) 0.77
Helicobacter pylori and gastritis. Dig Dis Sci (1992) 0.75
Autoimmune gastritis: is Helicobacter pylori a merely commensal or a pathogenic agent? Dig Dis Sci (1992) 0.75
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube. J Clin Microbiol (1983) 5.77
Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66
Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62
Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60
Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23
Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J Clin Invest (1971) 4.18
Some aspects of anal continence and defaecation. Gut (1965) 4.02
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68
A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43
Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34
Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01
Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00
The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96
The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol (1980) 2.93
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82
Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology (1987) 2.80
Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73
Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69
Crohn's disease and cancer. N Engl J Med (1973) 2.68
Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67
Anaerobic bacteremia: decreasing rate over a 15-year period. Rev Infect Dis (1991) 2.65
Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
Perfusion of the canine colon with unconjugated bile acids. Effect on water and electrolyte transport, morphology, and bile acid absorption. Gastroenterology (1970) 2.43
The antimicrobial removal device. A microbiological and clinical evaluation. Am J Clin Pathol (1982) 2.40
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38
Antimicrobial susceptibilities of species of viridans streptococci. J Infect Dis (1979) 2.37
Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36
Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc (1997) 2.36
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35
Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology (1990) 2.32
Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc (1994) 2.23
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23
Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol (1997) 2.23
Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology (1995) 2.23
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22
Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther (2015) 2.17
Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med (1988) 2.17
N-Substituted 2-(2,6-dinitrophenylamino)propanamides: novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization. J Med Chem (1999) 2.13
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12
Recent developments in "nonspecific" inflammatory bowel disease (first of two parts). N Engl J Med (1982) 2.12
Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09
Conservation of sodium, chloride, and water by the human colon. Gastroenterology (1969) 2.08
Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg (2000) 2.05
The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther (2014) 2.05
Infective endocarditis caused by HACEK microorganisms. Annu Rev Med (1997) 2.03
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology (1993) 2.03
The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol (1985) 2.01
Human interdigestive motility: variations in patterns from esophagus to colon. Gastroenterology (1986) 2.00
Prospective evaluation of the risk of bacteremia associated with transesophageal echocardiography. Circulation (1991) 1.99
A comparison of stable and 14 C-labelled polyethylene glycol as volume indicators in the human jejunum. Gut (1972) 1.98
Ceftriaxone sodium therapy of penicillin G-susceptible streptococcal endocarditis. JAMA (1992) 1.97
Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med (1990) 1.96
Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96
Erythromycin: a microbial and clinical perspective after 30 years of clinical use (2). Mayo Clin Proc (1985) 1.93
DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258) J Med Chem (1994) 1.93
G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Nat Neurosci (1999) 1.92
Control of gastric emptying by osmolality of duodenal contents in man. Gastroenterology (1975) 1.92
Effects of oleic and ricinoleic acids on net jejunal water and electrolyte movement. Perfusion studies in man. J Clin Invest (1974) 1.92
Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology (1977) 1.92
Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1). Mayo Clin Proc (1985) 1.91
Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon. J Clin Invest (1975) 1.91
Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol (1990) 1.90
Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA (1997) 1.89
A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease. Am J Dig Dis (1972) 1.89
Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms. Am J Gastroenterol (1998) 1.88
The contribution of the colon to electrolyte and water conservation in man. J Lab Clin Med (1973) 1.88
AGA technical review on constipation. American Gastroenterological Association. Gastroenterology (2000) 1.87
Occlusion of the jejunum for intestinal perfusion in man. Mayo Clin Proc (1966) 1.85
Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol (1994) 1.85
Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial. Gastroenterology (1996) 1.85
Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol (2001) 1.85
Capacity of the human colon to absorb fluid. Gastroenterology (1978) 1.85
Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol (2001) 1.84
Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study. Aliment Pharmacol Ther (2003) 1.84
In vitro studies of inflammatory bowel disease. Surface receptors of the mononuclear cell required to lyse allogeneic colonic epithelial cells. Gastroenterology (1976) 1.83
Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut (1988) 1.82
Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther (2007) 1.81
Recent developments in nonspecific inflammatory bowel disease (second of two parts). N Engl J Med (1982) 1.80